Global Canine Cancer Market Outlook
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
The global Canine cancer market size was estimated at USD 199.9 million in 2019 and is anticipated to witness a CAGR of 10.7% during the forecast period. The increasing pervasiveness of cancer in the pet population and rising adoption of Canine cancer therapy as a treatment method are propelling the market growth. Growing expenditure on animal healthcare in the developed economies due to rising willingness to spend on pet healthcare by owners and initiatives by government for the Canine cancer treatment are the major factors driving the market growth
.
Top Driver: Growing demand for ready to eat food will drive the market growth
The increasing number of veterinary clinical studies for evaluating the safety and efficacy of different oncology treatments in pets is further boosting the market growth. AVMA created a database called AVMA Animal Health Studies Database (AAHSD) as a tool for investigators performing prospective veterinary clinical studies. Such studies by the researchers focused on veterinary oncology treatment are anticipated to fuel the market growth over the forecast period. The rising number of these cancer incidents, there is a necessity for effective veterinary oncology treatment in these animals.
Chemotherapy to Make Crucial Contribution for Growth of Global Canine cancer Market
By Therapy, The chemotherapy segment held the largest market share in terms of revenue in 2019 owing to the increasing number of chemotherapeutic procedures adopted by surgeons due to their several advantages. According to the oncology guidelines by AAHA, chemotherapy is a commonly used veterinary oncology treatment modality in Canine cancer medicine. Moreover, other chemotherapy methods such as conventional, metronomic, and targeted chemotherapy including Tyrosine Kinase Inhibitors are adopted by small animal practitioners. Therefore, the rising adoption of chemotherapy as a treatment modality for cancer in pets is expected to fuel the veterinary oncology market growth. Chemotherapy is followed by radiology treatment due to increasing research studies to test the safety and efficacy of Stereotactic Radiosurgery Treatment in animals. SRT helps control the tumor to an extent and ultimately reduces its toxicity.
The lymphoma cancer type segment accounted for the largest share of revenue in 2019, owing to the increasing number of the pet population, especially canine, being affected by the disease, an estimated incidence rate of 20-100 cases per 100,000 dogs are contracted by this disease. The proven oncology treatment for lymphoma is chemotherapy, which also varies depending on the type of cancer. According to American Kennel Club, the most common types of lymphoma in dogs are mediastinal lymphoma, multicentric lymphoma, alimentary lymphoma, and extranodal lymphoma, which vary in survival rates, aggressiveness, and clinical signs. The organization also states that 80 to 85 % of lymphomas in dogs were found to be multicentric. Lymphoma is followed by mast cell cancer along with mammary and squamous cell cancer. The rising incidence of mast cell cancer in dogs is further expected to drive market growth.
North America dominated to witness the fastest growth in Global Canine cancer Market
North America is projected to dominate the market over the forecast period. Major factors attributed to the market growth are increasing focus on pet health, the presence of a large number of pet drug manufacturing companies, and speedy adoption of innovative pet care medications. In addition, the increased funding for pet oncology treatment in this region by the government and the presence of market giants in the oncology market is also driving the market growth.
The European market is anticipated to be the second-largest region in terms of revenue due to the presence of regulatory authorities focused on scientific progress in veterinary and comparative oncology. These authorities collaborate with big market players to focus on developing unparalleled therapeutic solutions for pet oncology.
Players to Focus on Canine cancer Market
Some of the key players in the market are,
PetCure Oncology;
Accuray Incorporated;
Varian Medical Systems;
Boehringer Ingelheim;
Elanco;
Zoetis Karyopharm Therapeutics, Inc.;
One Health;
Regeneus Ltd.
National Cancer Institute: For instance, in July 2019, the National Cancer Institute (NCI) supported clinical trial testing for veterinary oncology treatments in animals. The aim of the trials offered by veterinary medical schools worldwide was to find new cancer treatments that will preserve the dogs quality of life. The trial was also conducted to provide an insight into how the veterinary oncology treatments and approaches being examined in dogs may be translated to help people with cancer, as humans and dogs share similar biology for cancer.
Scope of the Report
By Cancer Type
Lymphoma
Mast Cell Cancer
Mammary and Squamous Cell Cancer
By Therapy
Radiology
Chemotherapy
Immunotherapy
By Region
North America
Europe
Asia Pacific
Rest Of World
Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
.
Top Driver: Growing demand for ready to eat food will drive the market growth
The increasing number of veterinary clinical studies for evaluating the safety and efficacy of different oncology treatments in pets is further boosting the market growth. AVMA created a database called AVMA Animal Health Studies Database (AAHSD) as a tool for investigators performing prospective veterinary clinical studies. Such studies by the researchers focused on veterinary oncology treatment are anticipated to fuel the market growth over the forecast period. The rising number of these cancer incidents, there is a necessity for effective veterinary oncology treatment in these animals.
Chemotherapy to Make Crucial Contribution for Growth of Global Canine cancer Market
By Therapy, The chemotherapy segment held the largest market share in terms of revenue in 2019 owing to the increasing number of chemotherapeutic procedures adopted by surgeons due to their several advantages. According to the oncology guidelines by AAHA, chemotherapy is a commonly used veterinary oncology treatment modality in Canine cancer medicine. Moreover, other chemotherapy methods such as conventional, metronomic, and targeted chemotherapy including Tyrosine Kinase Inhibitors are adopted by small animal practitioners. Therefore, the rising adoption of chemotherapy as a treatment modality for cancer in pets is expected to fuel the veterinary oncology market growth. Chemotherapy is followed by radiology treatment due to increasing research studies to test the safety and efficacy of Stereotactic Radiosurgery Treatment in animals. SRT helps control the tumor to an extent and ultimately reduces its toxicity.
The lymphoma cancer type segment accounted for the largest share of revenue in 2019, owing to the increasing number of the pet population, especially canine, being affected by the disease, an estimated incidence rate of 20-100 cases per 100,000 dogs are contracted by this disease. The proven oncology treatment for lymphoma is chemotherapy, which also varies depending on the type of cancer. According to American Kennel Club, the most common types of lymphoma in dogs are mediastinal lymphoma, multicentric lymphoma, alimentary lymphoma, and extranodal lymphoma, which vary in survival rates, aggressiveness, and clinical signs. The organization also states that 80 to 85 % of lymphomas in dogs were found to be multicentric. Lymphoma is followed by mast cell cancer along with mammary and squamous cell cancer. The rising incidence of mast cell cancer in dogs is further expected to drive market growth.
North America dominated to witness the fastest growth in Global Canine cancer Market
North America is projected to dominate the market over the forecast period. Major factors attributed to the market growth are increasing focus on pet health, the presence of a large number of pet drug manufacturing companies, and speedy adoption of innovative pet care medications. In addition, the increased funding for pet oncology treatment in this region by the government and the presence of market giants in the oncology market is also driving the market growth.
The European market is anticipated to be the second-largest region in terms of revenue due to the presence of regulatory authorities focused on scientific progress in veterinary and comparative oncology. These authorities collaborate with big market players to focus on developing unparalleled therapeutic solutions for pet oncology.
Players to Focus on Canine cancer Market
Some of the key players in the market are,
PetCure Oncology;
Accuray Incorporated;
Varian Medical Systems;
Boehringer Ingelheim;
Elanco;
Zoetis Karyopharm Therapeutics, Inc.;
One Health;
Regeneus Ltd.
National Cancer Institute: For instance, in July 2019, the National Cancer Institute (NCI) supported clinical trial testing for veterinary oncology treatments in animals. The aim of the trials offered by veterinary medical schools worldwide was to find new cancer treatments that will preserve the dogs quality of life. The trial was also conducted to provide an insight into how the veterinary oncology treatments and approaches being examined in dogs may be translated to help people with cancer, as humans and dogs share similar biology for cancer.
Scope of the Report
By Cancer Type
Lymphoma
Mast Cell Cancer
Mammary and Squamous Cell Cancer
By Therapy
Radiology
Chemotherapy
Immunotherapy
By Region
North America
Europe
Asia Pacific
Rest Of World
Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
TABLE OF CONTENTS
Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted
Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Canine cancer Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition
Chapter 6 Global Canine cancer Market -Industry Snapshots
6.1 Overview
6.1.1 Global Canine cancer Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis
Chapter 7 Global Canine cancer Market Analysis, by Cancer Type
7.1 Overview
7.2 Key Findings for Canine cancer Market- By Cancer Type
7.2.1 Canine cancer Market- Lymphoma
7.2.2 Canine cancer Market- Mast Cell Cancer
7.2.3 Canine cancer Market- Mammary and Squamous Cell Cancer
Chapter 8 Global Canine cancer Market Analysis, by Product Therapy Type
8.1 Overview
8.2 Key Findings for Canine cancer Market- By Therapy Type
8.2.1 Canine cancer Market- Radiology
8.2.2 Canine cancer Market- Chemotherapy
Canine cancer market by Therapy Type 2, 2019 - 2028 (USD Million)
8.2.3 Canine cancer Market- Immunotherapy
Chapter 9 Canine cancer Market Analysis by Region
9.1 Key Findings for Canine cancer Market- By region
9.2 Overview
9.2.1 Global Canine cancer Market Analysis, By Type, 2019 - 2028
9.2.2 Global Canine cancer Market Analysis, By Product Type, 2019 - 2028
9.3 Canine cancer Market North America
9.3.1 Overview
9.3.2 U.S.
9.3.3 Canada
9.3.4 Mexico
9.3.5 North America Market, By Type
9.3.6 North America Market, By Product Type
9.4 Canine cancer Market Europe
9.4.1 Overview
9.4.2 Germany
9.4.3 United Kingdom
9.4.4 France
9.4.5 Italy
9.4.6 Rest Of Europe
9.4.7 Europe Market, By Type
9.4.8 Europe Market, By Product Type
9.5 Canine cancer Market Asia Pacific
9.5.1 Overview
9.5.2 China
9.5.3 Japan
9.5.4 India
9.5.5 Rest of APAC
9.5.6 Asia Pacific Market, By Type
9.5.7 Asia Pacific Market, By Product Type
9.6 Canine cancer Market SAMA
9.6.1 Overview
9.6.2 Middle East & Africa (MEA)
9.6.3 South America
9.6.4 Rest Of World
9.6.5 South America, Middle East and Africa Market, By Type
9.6.6 South America, Middle East and Africa Market, By Product Type
Chapter 10 Market Competition Analysis
10.1 Market Share/Positioning Analysis
10.1.1 Market Positioning of Key Vendors, 2019
10.1.2 Key Strategies Adopted by the Leading Players
10.1.3 Recent Developments
Chapter 11 Company Profiles- Snapshot
11.1 Regeneus Ltd.
11.1.1 Business Fundamentals
11.1.2 Financial Snapshots
11.1.3 Product Portfolio
11.1.4 Recent Developments
11.2 PetCure Oncology;
11.3 Accuray Incorporated;
11.4 Varian Medical Systems;
11.5 Boehringer Ingelheim;
11.6 Elanco;
11.7 Zoetis Karyopharm Therapeutics, Inc.;
11.8 One Health;
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies
Chapter 12 Appendix
TABLE 2 Canine cancer market by Cancer Type 2, 2019 - 2028 (USD Million)
TABLE 3 Canine cancer market byCancer Type 3, 2019 - 2028 (USD Million)
TABLE 4 Canine cancer market by Therapy Type 1, 2019 - 2028 (USD Million)
TABLE 5 Canine cancer market by Therapy Type 3, 2019 - 2028 (USD Million)
TABLE 6 Global Canine cancer Market Value, By Type, 2019 - 2028 (US$ Bn)
TABLE 7 Global Canine cancer Market Value, By Product Type, 2019 - 2028 (US$ Bn)
TABLE 8 Canine cancer Market Analysis by North America (USD Million), 2019 - 2028
TABLE 9 U.S. Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 10 U.S. Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 11 U.S. Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 12 Canada Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 13 Canada Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 14 Canada Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 15 Mexico Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 16 Mexico Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 17 Mexico Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 18 Canine cancer Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 19 Germany Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 20 Germany Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 21 Germany Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 22 United Kingdom Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 23 United Kingdom Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 24 United Kingdom Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 25 France Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 26 France Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 27 France Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 28 Italy Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 29 Italy Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 30 Italy Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 31 Rest Of Europe Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 32 Rest Of Europe Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 33 Rest Of Europe Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 34 Canine cancer Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 35 China Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 36 China Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 37 China Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 38 Japan Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 39 Japan Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 40 Japan Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 41 India Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 42 India Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 43 India Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 44 Rest of APAC Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 45 Rest of APAC Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 46 Rest of APAC Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 47 Canine cancer Market Analysis by SAMA (USD Million), 2019 - 2028
TABLE 48 Middle East & Africa (MEA) Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 49 Middle East & Africa (MEA) Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 50 Middle East & Africa (MEA) Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 51 South America Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 52 South America Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 53 South America Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 54 Rest Of World Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 55 Rest Of World Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 56 Rest Of World Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
FIG. 2 Global Canine cancer Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Canine cancer Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Canine cancer Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Canine cancer Market Value Contribution, By Product Type, 2019 & 2026 (%)
FIG. 10 Global Canine cancer Market Value, 2019 - 2028, (US$ Bn)
FIG. 11 North America Canine cancer Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 Canine cancer Market Segment 1 North America
FIG. 13 Canine cancer Market Segment 2 North America
FIG. 14 Canine cancer U.S. outlook, 2019 & 2026
FIG. 15 Canine cancer Canada outlook, 2019 & 2026
FIG. 16 Canine cancer Mexico outlook, 2019 & 2026
FIG. 17 Europe Canine cancer Market Value, 2019 - 2028, (US$ Bn)
FIG. 18 Canine cancer Market Segment 1 Europe
FIG. 19 Canine cancer Market Segment 2 Europe
FIG. 20 Canine cancer Germany outlook, 2019 & 2026
FIG. 21 Canine cancer United Kingdom outlook, 2019 & 2026
FIG. 22 Canine cancer France outlook, 2019 & 2026
FIG. 23 Canine cancer Italy outlook, 2019 & 2026
FIG. 24 Canine cancer Rest Of Europe outlook, 2019 & 2026
FIG. 25 Asia Pacific Canine cancer Market Value, 2019 - 2028, (US$ Bn)
FIG. 26 Canine cancer Market Segment 1 Asia Pacific
FIG. 27 Canine cancer Market Segment 2 Asia Pacific
FIG. 28 Canine cancer China outlook, 2019 & 2026
FIG. 29 Canine cancer Japan outlook, 2019 & 2026
FIG. 30 Canine cancer India outlook, 2019 & 2026
FIG. 31 Canine cancer Rest of APAC outlook, 2019 & 2026
FIG. 32 SAMA Canine cancer Market Value, 2019 - 2028, (US$ Bn)
FIG. 33 Canine cancer Market Segment 1 SAMA
FIG. 34 Canine cancer Market Segment 2 SAMA
FIG. 35 Canine cancer Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 36 Canine cancer South America outlook, 2019 & 2026
FIG. 37 Canine cancer Rest Of World outlook, 2019 & 2026
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted
Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Canine cancer Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition
Chapter 6 Global Canine cancer Market -Industry Snapshots
6.1 Overview
6.1.1 Global Canine cancer Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis
Chapter 7 Global Canine cancer Market Analysis, by Cancer Type
7.1 Overview
7.2 Key Findings for Canine cancer Market- By Cancer Type
7.2.1 Canine cancer Market- Lymphoma
7.2.2 Canine cancer Market- Mast Cell Cancer
7.2.3 Canine cancer Market- Mammary and Squamous Cell Cancer
Chapter 8 Global Canine cancer Market Analysis, by Product Therapy Type
8.1 Overview
8.2 Key Findings for Canine cancer Market- By Therapy Type
8.2.1 Canine cancer Market- Radiology
8.2.2 Canine cancer Market- Chemotherapy
Canine cancer market by Therapy Type 2, 2019 - 2028 (USD Million)
8.2.3 Canine cancer Market- Immunotherapy
Chapter 9 Canine cancer Market Analysis by Region
9.1 Key Findings for Canine cancer Market- By region
9.2 Overview
9.2.1 Global Canine cancer Market Analysis, By Type, 2019 - 2028
9.2.2 Global Canine cancer Market Analysis, By Product Type, 2019 - 2028
9.3 Canine cancer Market North America
9.3.1 Overview
9.3.2 U.S.
9.3.3 Canada
9.3.4 Mexico
9.3.5 North America Market, By Type
9.3.6 North America Market, By Product Type
9.4 Canine cancer Market Europe
9.4.1 Overview
9.4.2 Germany
9.4.3 United Kingdom
9.4.4 France
9.4.5 Italy
9.4.6 Rest Of Europe
9.4.7 Europe Market, By Type
9.4.8 Europe Market, By Product Type
9.5 Canine cancer Market Asia Pacific
9.5.1 Overview
9.5.2 China
9.5.3 Japan
9.5.4 India
9.5.5 Rest of APAC
9.5.6 Asia Pacific Market, By Type
9.5.7 Asia Pacific Market, By Product Type
9.6 Canine cancer Market SAMA
9.6.1 Overview
9.6.2 Middle East & Africa (MEA)
9.6.3 South America
9.6.4 Rest Of World
9.6.5 South America, Middle East and Africa Market, By Type
9.6.6 South America, Middle East and Africa Market, By Product Type
Chapter 10 Market Competition Analysis
10.1 Market Share/Positioning Analysis
10.1.1 Market Positioning of Key Vendors, 2019
10.1.2 Key Strategies Adopted by the Leading Players
10.1.3 Recent Developments
Chapter 11 Company Profiles- Snapshot
11.1 Regeneus Ltd.
11.1.1 Business Fundamentals
11.1.2 Financial Snapshots
11.1.3 Product Portfolio
11.1.4 Recent Developments
11.2 PetCure Oncology;
11.3 Accuray Incorporated;
11.4 Varian Medical Systems;
11.5 Boehringer Ingelheim;
11.6 Elanco;
11.7 Zoetis Karyopharm Therapeutics, Inc.;
11.8 One Health;
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies
Chapter 12 Appendix
List Of Tables
TABLE 1 Canine cancer market by Cancer Type 1, 2019 - 2028 (USD Million)TABLE 2 Canine cancer market by Cancer Type 2, 2019 - 2028 (USD Million)
TABLE 3 Canine cancer market byCancer Type 3, 2019 - 2028 (USD Million)
TABLE 4 Canine cancer market by Therapy Type 1, 2019 - 2028 (USD Million)
TABLE 5 Canine cancer market by Therapy Type 3, 2019 - 2028 (USD Million)
TABLE 6 Global Canine cancer Market Value, By Type, 2019 - 2028 (US$ Bn)
TABLE 7 Global Canine cancer Market Value, By Product Type, 2019 - 2028 (US$ Bn)
TABLE 8 Canine cancer Market Analysis by North America (USD Million), 2019 - 2028
TABLE 9 U.S. Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 10 U.S. Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 11 U.S. Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 12 Canada Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 13 Canada Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 14 Canada Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 15 Mexico Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 16 Mexico Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 17 Mexico Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 18 Canine cancer Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 19 Germany Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 20 Germany Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 21 Germany Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 22 United Kingdom Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 23 United Kingdom Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 24 United Kingdom Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 25 France Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 26 France Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 27 France Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 28 Italy Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 29 Italy Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 30 Italy Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 31 Rest Of Europe Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 32 Rest Of Europe Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 33 Rest Of Europe Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 34 Canine cancer Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 35 China Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 36 China Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 37 China Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 38 Japan Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 39 Japan Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 40 Japan Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 41 India Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 42 India Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 43 India Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 44 Rest of APAC Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 45 Rest of APAC Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 46 Rest of APAC Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 47 Canine cancer Market Analysis by SAMA (USD Million), 2019 - 2028
TABLE 48 Middle East & Africa (MEA) Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 49 Middle East & Africa (MEA) Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 50 Middle East & Africa (MEA) Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 51 South America Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 52 South America Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 53 South America Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 54 Rest Of World Canine cancer Market, 2019 - 2028 (USD Million)
TABLE 55 Rest Of World Canine cancer Market, By Type, 2019 - 2028 (USD Million)
TABLE 56 Rest Of World Canine cancer Market, By Product Type, 2019 - 2028 (USD Million)
List Of Figures
FIG. 1 Global Canine cancer: Market SegmentationFIG. 2 Global Canine cancer Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Canine cancer Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Canine cancer Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Canine cancer Market Value Contribution, By Product Type, 2019 & 2026 (%)
FIG. 10 Global Canine cancer Market Value, 2019 - 2028, (US$ Bn)
FIG. 11 North America Canine cancer Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 Canine cancer Market Segment 1 North America
FIG. 13 Canine cancer Market Segment 2 North America
FIG. 14 Canine cancer U.S. outlook, 2019 & 2026
FIG. 15 Canine cancer Canada outlook, 2019 & 2026
FIG. 16 Canine cancer Mexico outlook, 2019 & 2026
FIG. 17 Europe Canine cancer Market Value, 2019 - 2028, (US$ Bn)
FIG. 18 Canine cancer Market Segment 1 Europe
FIG. 19 Canine cancer Market Segment 2 Europe
FIG. 20 Canine cancer Germany outlook, 2019 & 2026
FIG. 21 Canine cancer United Kingdom outlook, 2019 & 2026
FIG. 22 Canine cancer France outlook, 2019 & 2026
FIG. 23 Canine cancer Italy outlook, 2019 & 2026
FIG. 24 Canine cancer Rest Of Europe outlook, 2019 & 2026
FIG. 25 Asia Pacific Canine cancer Market Value, 2019 - 2028, (US$ Bn)
FIG. 26 Canine cancer Market Segment 1 Asia Pacific
FIG. 27 Canine cancer Market Segment 2 Asia Pacific
FIG. 28 Canine cancer China outlook, 2019 & 2026
FIG. 29 Canine cancer Japan outlook, 2019 & 2026
FIG. 30 Canine cancer India outlook, 2019 & 2026
FIG. 31 Canine cancer Rest of APAC outlook, 2019 & 2026
FIG. 32 SAMA Canine cancer Market Value, 2019 - 2028, (US$ Bn)
FIG. 33 Canine cancer Market Segment 1 SAMA
FIG. 34 Canine cancer Market Segment 2 SAMA
FIG. 35 Canine cancer Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 36 Canine cancer South America outlook, 2019 & 2026
FIG. 37 Canine cancer Rest Of World outlook, 2019 & 2026
RELATED REPORTS
Global Hematology Flow Cytometry Database
2024 Global Hematology and Flow Cytometry Database: US, Europe, Japan--Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts This database from provides the 2023 supplier shares, the 2023-2028
View ReportGlobal Hematology Market Shares Competitive Analysis
2023 Global Hematology Market Shares in the US, Europe, and Japan--Competitive Analysis of Leading and Emerging Market Players This new report provides hematology market shares for France, Germany, Italy, Japan,
View ReportGlobal Canine Atopic Dermatitis Market Outlook
Global Canine Atopic Dermatitis Market is anticipated to rise at a value CAGR of 9.1% over 2019-2028. Global Canine Atopic Dermatitis Market, Canine atopic dermatitis is a commonly found skin
View ReportCOVID-19 Outbreak-Global Canine Atopic Dermatitis Treatment Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
The Canine Atopic Dermatitis Treatment market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.Under COVID-19 outbreak
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
